Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

NASDAQ:SANA

Overview | Financials
Company Name Sana Biotechnology, Inc.
Symbol SANA
Currency USD
Price 4.06
Market Cap 903,211,960
Dividend Yield 0%
52-week-range 2.745 - 12
Industry Biotechnology
Sector Healthcare
CEO Dr. Steven D. Harr M.D.
Website https://www.sana.com

An error occurred while fetching data.

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295

Related Stocks

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

39.32 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

12.28 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

19.89 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

61.09 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.17 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

10.6 USD

National Research Corporation logo

National Research Corporation

NRC

19.75 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

18.09 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

0.395 USD

Financials

Numbers are in millions USD

Numbers are in millions USD